All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-PI3 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-3481-FY | CBFYE-1589 | Mouse | Human | IgG1 | Recognizes human leukocyte elastase | |
DMAb-3482-FY | CBFYE-1590 | Mouse | Human | IgG2b | Recognizes fully processed human Elafin. Weakly recognizes human native full-length Elafin. Recognizes all known Trappins via the GQDPVK epitope. For detection of human native full-length Elafin use E2225 | |
DMAb-3483-FY | CBFYE-1591 | Mouse | Human | IgG1 | Recognizes human native full-length Elafin. Weakly recognizes fully processed Elafin. Recognizes all known Trappins via the GQDPVK epitope. Cross reacts with Trappin family members of other species with GQDPVK epitope. For detection of fully processed Elafin use E2225-01 | |
DMAb-3484-FY | CBFYE-1592 | Human | IgG1 | |||
DMAb-3485-FY | CBFYE-1593 | Mouse | Human | IgG1, κ | Full length recombinant corresponding to aa1-118 from human PI3 with GST tag. MW of the GST tag alone is 26kD. | |
DMAb-3486-FY | CBFYE-1594 | Rabbit | Human | IgG | ||
DMAb-3487-FY | CBFYE-1595 | Mouse | Human | IgG2b | ||
DMAb-4032-FY | CBFYA-0098 | Mouse | Human | IgG1 | ||
DMAb-4033-FY | TRAB2F | Mouse | Human | IgG2b | ||
DMAb-3867CQ | CBXS-0053 | Mouse | Peptidase Inhibitor 3, Skin Derived |
There are currently no customer reviews or questions for Anti-PI3 DNA-encoded mAb (DMAb), pVAX1 (DMAb-3481-FY). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION